Early-Onset Methemoglobinemia in an HIV Patient Receiving Dapsone for PCP Prophylaxis Without G6PD Deficiency: A Case Report
Dapsone is used for Pneumocystis jirovecii pneumonia (PCP) prophylaxis in patients with human immunodeficiency virus (HIV) infection who cannot tolerate trimethoprim–sulfamethoxazole (TMP-SMX), the first-line agent. Methemoglobinemia is a known adverse effect of dapsone, usually associated with gluc...
محفوظ في:
| المؤلفون الرئيسيون: | , , , |
|---|---|
| التنسيق: | Artigo |
| اللغة: | Inglês |
| منشور في: |
Infectious Diseases and Clinical Microbiology Specialty Society of Turkey
2026-07-01
|
| سلاسل: | Mediterranean Journal of Infection, Microbes and Antimicrobials |
| الموضوعات: | |
| الوصول للمادة أونلاين: | https://mjima.org/articles/early-onset-methemoglobinemia-in-an-hiv-patient-receiving-dapsone-for-pcp-prophylaxis-without-g6pd-deficiency-a-case-report/doi/mjima.galenos.2026.25590.22 |
| الوسوم: |
لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!
|